Dendritic cells in hepatitis C infection: Can they (help) win the battle?

Angela Dolganiuc, G. Szabó

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Infection with hepatitis C virus (HCV) is a public health problem; it establishes a chronic course in ∼ 85% of infected patients and increases their risk for developing liver cirrhosis, hepatocellular carcinoma, and significant extrahepatic manifestations. The mechanisms of HCV persistence remain elusive and are largely related to inefficient clearance of the virus by the host immune system. Dendritic cells (DCs) are the most efficient inducers of immune responses; they are capable of triggering productive immunity and maintaining the state of tolerance to self-and non-self antigens. During the past decade, multiple research groups have focused on DCs, in hopes of unraveling an HCV-specific DC signature or DC-dependent mechanisms of antiviral immunity which would lead to a successful HCV elimination strategy. This review incorporates the latest update in the current status of knowledge on the role of DCs in anti-HCV immunity as it relates to several challenging questions: (a) the phenotype and function of diverse DC subsets in HCV-infected patients; (b) the characteristics of non-human HCV infection models from the DCs' point of view; (c) how can in vitro systems, ranging from HCV protein- or peptide-exposed DC to HCV protein-expressing DCs, and in vivo systems, ranging from HCV protein-expressing transgenic mice to HCV-infected non-human primates, be employed to dissect the role of DCs in triggering/maintaining a robust antiviral response; and (d) the prospect of DC-based strategy for managing and finding a cure for HCV infection.

Original languageEnglish
Pages (from-to)432-447
Number of pages16
JournalJournal of Gastroenterology
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2011

Fingerprint

Hepatitis C
Hepacivirus
Dendritic Cells
Infection
Immunity
Virus Diseases
Antiviral Agents
Proteins
Liver Cirrhosis
Primates
Transgenic Mice
Hepatocellular Carcinoma
Immune System
Public Health
Viruses
Phenotype
Antigens

Keywords

  • Immunity
  • Lymphocytes
  • Maturation
  • Protection
  • Vaccine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Dendritic cells in hepatitis C infection : Can they (help) win the battle? / Dolganiuc, Angela; Szabó, G.

In: Journal of Gastroenterology, Vol. 46, No. 4, 04.2011, p. 432-447.

Research output: Contribution to journalReview article

@article{1d85de5022324b47b807ed74fc58a672,
title = "Dendritic cells in hepatitis C infection: Can they (help) win the battle?",
abstract = "Infection with hepatitis C virus (HCV) is a public health problem; it establishes a chronic course in ∼ 85{\%} of infected patients and increases their risk for developing liver cirrhosis, hepatocellular carcinoma, and significant extrahepatic manifestations. The mechanisms of HCV persistence remain elusive and are largely related to inefficient clearance of the virus by the host immune system. Dendritic cells (DCs) are the most efficient inducers of immune responses; they are capable of triggering productive immunity and maintaining the state of tolerance to self-and non-self antigens. During the past decade, multiple research groups have focused on DCs, in hopes of unraveling an HCV-specific DC signature or DC-dependent mechanisms of antiviral immunity which would lead to a successful HCV elimination strategy. This review incorporates the latest update in the current status of knowledge on the role of DCs in anti-HCV immunity as it relates to several challenging questions: (a) the phenotype and function of diverse DC subsets in HCV-infected patients; (b) the characteristics of non-human HCV infection models from the DCs' point of view; (c) how can in vitro systems, ranging from HCV protein- or peptide-exposed DC to HCV protein-expressing DCs, and in vivo systems, ranging from HCV protein-expressing transgenic mice to HCV-infected non-human primates, be employed to dissect the role of DCs in triggering/maintaining a robust antiviral response; and (d) the prospect of DC-based strategy for managing and finding a cure for HCV infection.",
keywords = "Immunity, Lymphocytes, Maturation, Protection, Vaccine",
author = "Angela Dolganiuc and G. Szab{\'o}",
year = "2011",
month = "4",
doi = "10.1007/s00535-011-0377-y",
language = "English",
volume = "46",
pages = "432--447",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Dendritic cells in hepatitis C infection

T2 - Can they (help) win the battle?

AU - Dolganiuc, Angela

AU - Szabó, G.

PY - 2011/4

Y1 - 2011/4

N2 - Infection with hepatitis C virus (HCV) is a public health problem; it establishes a chronic course in ∼ 85% of infected patients and increases their risk for developing liver cirrhosis, hepatocellular carcinoma, and significant extrahepatic manifestations. The mechanisms of HCV persistence remain elusive and are largely related to inefficient clearance of the virus by the host immune system. Dendritic cells (DCs) are the most efficient inducers of immune responses; they are capable of triggering productive immunity and maintaining the state of tolerance to self-and non-self antigens. During the past decade, multiple research groups have focused on DCs, in hopes of unraveling an HCV-specific DC signature or DC-dependent mechanisms of antiviral immunity which would lead to a successful HCV elimination strategy. This review incorporates the latest update in the current status of knowledge on the role of DCs in anti-HCV immunity as it relates to several challenging questions: (a) the phenotype and function of diverse DC subsets in HCV-infected patients; (b) the characteristics of non-human HCV infection models from the DCs' point of view; (c) how can in vitro systems, ranging from HCV protein- or peptide-exposed DC to HCV protein-expressing DCs, and in vivo systems, ranging from HCV protein-expressing transgenic mice to HCV-infected non-human primates, be employed to dissect the role of DCs in triggering/maintaining a robust antiviral response; and (d) the prospect of DC-based strategy for managing and finding a cure for HCV infection.

AB - Infection with hepatitis C virus (HCV) is a public health problem; it establishes a chronic course in ∼ 85% of infected patients and increases their risk for developing liver cirrhosis, hepatocellular carcinoma, and significant extrahepatic manifestations. The mechanisms of HCV persistence remain elusive and are largely related to inefficient clearance of the virus by the host immune system. Dendritic cells (DCs) are the most efficient inducers of immune responses; they are capable of triggering productive immunity and maintaining the state of tolerance to self-and non-self antigens. During the past decade, multiple research groups have focused on DCs, in hopes of unraveling an HCV-specific DC signature or DC-dependent mechanisms of antiviral immunity which would lead to a successful HCV elimination strategy. This review incorporates the latest update in the current status of knowledge on the role of DCs in anti-HCV immunity as it relates to several challenging questions: (a) the phenotype and function of diverse DC subsets in HCV-infected patients; (b) the characteristics of non-human HCV infection models from the DCs' point of view; (c) how can in vitro systems, ranging from HCV protein- or peptide-exposed DC to HCV protein-expressing DCs, and in vivo systems, ranging from HCV protein-expressing transgenic mice to HCV-infected non-human primates, be employed to dissect the role of DCs in triggering/maintaining a robust antiviral response; and (d) the prospect of DC-based strategy for managing and finding a cure for HCV infection.

KW - Immunity

KW - Lymphocytes

KW - Maturation

KW - Protection

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=79959858141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959858141&partnerID=8YFLogxK

U2 - 10.1007/s00535-011-0377-y

DO - 10.1007/s00535-011-0377-y

M3 - Review article

C2 - 21327958

AN - SCOPUS:79959858141

VL - 46

SP - 432

EP - 447

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 4

ER -